Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,26999509,IC50,"The most potent analog, 5m, inhibits the pigment production of S. aureus Newman and three MRSA strains, with IC50 values of 0.38-5.45 nM, without any impact on the survival of four strains (up to 200 μM).",Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. ,IC50-Q10,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26999509/),nM,0.38-5.45,106335,DB00735,Naftifine
>,26999509,MIC,"Moreover, 5m was determined to be a weak antifungal reagent (MIC > 16 μg/mL).",Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26999509/),[μg] / [ml],16,106336,DB00735,Naftifine
,26999509,oral bioavailability (F,"Combined with good oral bioavailability (F = 42.2%) and excellent safety profiles, these data demonstrate that 5m may be a good candidate for the treatment of MRSA infections.",Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. ,F-Q40,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26999509/),%,42.2,106337,DB00735,Naftifine
,11802108,ch,The method has a chromatographic run time of 5 minutes and was linear in the range 1.0 to 2000 ng/mL.,Terbinafine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to a bioequivalence study. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11802108/),min,5,191915,DB00735,Naftifine
